Dr. Lal PathLabs (NSE:LALPATHLAB) COGS-to-Revenue : 0.34 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs COGS-to-Revenue?

Dr. Lal PathLabs's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹1,845 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹5,453 Mil.

Dr. Lal PathLabs's COGS to Revenue for the three months ended in Mar. 2024 was 0.34.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Dr. Lal PathLabs's Gross Margin % for the three months ended in Mar. 2024 was 66.16%.

Dr. Lal PathLabs COGS-to-Revenue Historical Data

The historical data trend for Dr. Lal PathLabs's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs COGS-to-Revenue Chart

Dr. Lal PathLabs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.22

0.38

0.24

0.36

0.34

Dr. Lal PathLabs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.36	0.35	0.35	0.34	0.34

Dr. Lal PathLabs COGS-to-Revenue Calculation

Dr. Lal PathLabs's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7644.29	/	22265.02
	=	0.34

Dr. Lal PathLabs's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1845.29	/	5453.02
	=	0.34

Dr. Lal PathLabs (NSE:LALPATHLAB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Dr. Lal PathLabs's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1845.29 / 5453.02
	=	66.16 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Dr. Lal PathLabs COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr. Lal PathLabs (NSE:LALPATHLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

539524:India

Address

12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001

Website

https://www.lalpathlabs.com

Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs (NSE:LALPATHLAB) Headlines

No Headlines